KEZAR LIFE SCIENCES INC's ticker is KZR and the CUSIP is 49372L100. A total of 138 filers reported holding KEZAR LIFE SCIENCES INC in Q1 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,677,251 | -75.1% | 4,770,799 | -48.7% | 1.80% | -47.3% |
Q2 2023 | $22,794,408 | +127.6% | 9,303,840 | +190.7% | 3.42% | -28.1% |
Q1 2023 | $10,016,000 | -18.9% | 3,200,000 | +82.4% | 4.75% | -29.5% |
Q4 2022 | $12,351,180 | +8.0% | 1,754,429 | +32.1% | 6.74% | +10.0% |
Q3 2022 | $11,433,000 | +9.5% | 1,327,899 | +5.2% | 6.12% | -25.6% |
Q2 2022 | $10,442,000 | +109.4% | 1,262,691 | +320.9% | 8.23% | +155.5% |
Q1 2022 | $4,986,000 | -17.2% | 300,000 | -16.7% | 3.22% | -10.6% |
Q4 2021 | $6,019,000 | +10.6% | 360,000 | -42.9% | 3.60% | +20.3% |
Q3 2021 | $5,443,000 | -2.1% | 629,957 | -38.5% | 3.00% | -13.8% |
Q2 2021 | $5,559,000 | +24.3% | 1,023,704 | +36.4% | 3.48% | -5.1% |
Q1 2021 | $4,472,000 | +152.5% | 750,310 | +105.0% | 3.66% | +334.9% |
Q3 2020 | $1,771,000 | +320.7% | 365,981 | +278.8% | 0.84% | +327.4% |
Q1 2020 | $421,000 | -67.2% | 96,615 | -69.8% | 0.20% | -65.0% |
Q4 2019 | $1,283,000 | +386.0% | 320,000 | +835.0% | 0.56% | +323.3% |
Q2 2019 | $264,000 | -76.4% | 34,224 | -34.6% | 0.13% | -78.7% |
Q3 2018 | $1,120,000 | +55.3% | 52,331 | +25.5% | 0.62% | +18.1% |
Q2 2018 | $721,000 | – | 41,691 | – | 0.53% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 3,200,000 | $10,016,000 | 4.75% |
Qiming U.S. Ventures Management, LLC | 828,711 | $2,593,865 | 3.14% |
SPHERA FUNDS MANAGEMENT LTD. | 1,888,228 | $5,910,154 | 0.99% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 6,887,591 | $21,558,160 | 0.91% |
Avidity Partners Management LP | 6,519,400 | $20,405,722 | 0.68% |
Ikarian Capital, LLC | 841,596 | $2,634,195 | 0.60% |
Opaleye Management Inc. | 625,000 | $1,956,250 | 0.59% |
CHI Advisors LLC | 689,451 | $2,157,982 | 0.57% |
Orbimed Advisors | 5,463,000 | $17,099,190 | 0.34% |
Palo Alto Investors LP | 656,200 | $2,053,906 | 0.17% |